Q-PCR analysis demonstrated that Sox2 and Oct4 expression levels were significantly reduced in xenograft sections from GBM-R2I2/sh-STAT3-transplanted mice compared with those from mice subjected to other treatments (Figure S4B). The gene discussed is SOX2; the disease is glioblastoma.